C. Lash

发表

Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.

W. Wilson, B. Baguley, L. J. Zwi, 1998, British Journal of Cancer.